Quality-of-life assessment for routine oncology clinical practice

Journal of Supportive Oncology

Volumn 6, Issue 5, 2008, Pages 221-229

  Halyard, Michele Y ^a   Ferrans, Carol Estwing ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTIANDROGEN; CYTARABINE; DOCETAXEL; GEMCITABINE; IMATINIB; LETROZOLE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; TAMOXIFEN;

BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER FATIGUE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DAILY LIFE ACTIVITY; DISEASE FREE SURVIVAL; DOCTOR PATIENT RELATION; DRUG DOSE SEQUENCE; DRUG WITHDRAWAL; FATIGUE; FEASIBILITY STUDY; HOT FLUSH; HUMAN; INFORMATION PROCESSING; LOW DRUG DOSE; LUNG SMALL CELL CANCER; MEDICAL INFORMATION SYSTEM; MONOTHERAPY; MULTIPLE MYELOMA; ONCOLOGY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SATISFACTION; PREDICTION; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; RECURRENT CANCER; REVIEW; SELF REPORT; SEXUAL DYSFUNCTION; SHORT FORM 36; SIDE EFFECT; SOLID TUMOR; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

HEALTH STATUS INDICATORS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE;

EID: 45249097365     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Bezjak A, Ng P, Skeel R, Depetrillo AD, Comis R, Taylor KM. Oncologists' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians. Qual Life Res 2001,10:113. [11508471]
2. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol 1996;14:671-679. [8636786]
3. Herndon JE 2nd, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999;85:333-340. [10023700]
4. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients:as an important prognostic factor. Lung Cancer 2001;31:233-240. [1165402]
5. Efficace F, Bottomley A, Coens C, et al. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 2006;42:42-49. [16298522]
6. Schaar CG, Kluin-Nelemans HC, Te Marvelde C, et al. Interferon-alpha as maintenance therapy in patients with multiple myeloma. Ann Oncol 2005;16:634-639. [15741226]
7. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-672. [17699816]
8. Amemiya T, Oda K, Ando M, et al. Activities of daily living and quality of life of elderly patients after elective surgery for gastric and colorectal cancers. Ann Surg 2007;246:222-228. [17667500]
9. Hahn EA, Cella D.Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil 2003;84(4 suppl 2):S35-S42. [12692770]
10. Citron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 19741. J Clin Oncol 2003;21:1431-1439. [12668651]
11. Hanks GE. External beam radiation treatment for prostate cancer: still the gold standard. Oncology (Williston Park] 1992;6:79-86, 89. [1533146]
12. Yarbro CH, Ferrans CE.Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum 1998;25:685-693. [9599352]
13. Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999;91:1719-1724. [10528021]
14. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-1592. [11018094]
15. van Andel G, Visser AP, Zwinderman AH, Hulshof MC, Horenblas S, Kurth KH.A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients. Prostate 2004;58:354-365. [14968436]
16. Parkin DM.Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543. [11905707]
17. Dancey J, Shepherd FA, Gralla RJ, Kim YS.Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 2004;43:183-194. [14739039]
18. Manegold C, Pilz LR, Koschel G, et al. Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer. Clin Lung Cancer 2005;7:208-214. [16354317]
19. Tamoxifen for early breast cancer:an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;351:1451-1467. [9605801]
20. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431-2442. [12802030]
21. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-1802. [14551341]
22. Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-1092. [15014181]
23. Buzdar AU; ATAC Trialists' group. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer - efficacy overview. J Steroid Biochem Mol Biol 2003;86:399-403. [14623537]
24. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003;98:1802-1810. [14584060]
25. de Castro G Jr. ATAC trial update. Lancet 2005;365:1225. [15811448]
26. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A.Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol 2004;22:4261-4271. [15514369]
27. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-523. [12544300]
28. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002;360:103-106. [12126818]
29. Black PC, Basen-Engquist K, Wang X, et al. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int 2007;100:63-69. [17552954]
30. Ferrans CE. Development of a quality of life index for patients with cancer. Oncol Nurs Forum 1990;17(3 suppl):15-19. [2342979]
31. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998;28:551-558. [9626712]
32. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:59-65. [7996652]
33. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK.Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002;288:3027-3034. [12479768]
34. Levinson W, Roter D. Physicians' psychosocial beliefs correlate with their patient communication skills. J Gen Intern Med 1995;10:375-379. [7472685]
35. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 2004;22:714-724. [14966096]
36. Taylor KM, Macdonald KG, Bezjak A, Ng P, DePetrillo AD. Physicians' perspective on quality of life:an exploratory study of oncologists. Qual Life Res 1996;5:5-14. [8901361]
37. Detmar SB, Muller MJ, Wever LD, Schornagel JH, Aaronson NK.The patient-physician relationship: patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA 2001;285:1351-1357. [11255393]
38. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353-360. [11040270]
39. Macquart-Moulin G, Viens P, Genre D, et al. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization. Cancer 1999;85:2190-2199. [10326697]
40. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34(3 suppl 2):4-12. [9253778]
41. Barton-Burke M. Cancer-related fatigue and sleep disturbances. Cancer Nurs 2006;29(2 suppl):72-77. [16779960]
42. Barton-Burke M. Cancer-related fatigue and sleep disturbances: further research on the prevalence of these two symptoms in long-term cancer survivors can inform education, policy, and clinical practice. Am J Nursing 2006;106:72-77. [16481861]
43. Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J.Correlation between physical performance and fatigue in cancer patients. Ann Oncol 1997;8:1251-1255. [9496391]
44. Blazeby JM, Williams MH, Alderson D, Farndon JR. Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg 1995;82:1200-1203. [7551995]
45. Sneeuw KC, Sprangers MA, Aaronson NK.The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 2002;55:1130-1143. [12507678]
46. Sprangers MA, Aaronson NK.The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 1992;45:743-760. [1619454]
47. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QOL data really any different than other medical testing? Curr Probl Cancer 2006;30:261-271. [17123878]
48. Greenhalgh J, Meadows K.The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review. J Eval Clin Pract 1999;5:401-416. [10579704]
49. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1-74. [9812244]
50. Ganz PA, Schag CA, Lee JJ, Sim MS.The CARES: a generic measure of health-related quality of life for patients with cancer. Qual Life Res 1992;1:19-29. [1301111]
51. Schag CA, Ganz PA, Heinrich RL. CAncer Rehabilitation Evaluation System - short form (CARES-SF): a cancer specific rehabilitation and quality of life instrument. Cancer 1991;68:1406-1413. [1873793]
52. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376. [8433390]
53. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055-1068. [9817123]
54. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995;12:199-220. [7655830]
55. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579. [8445433]
56. Cohen SR, Mount BM, Strobel MG, Bui F.The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease: a preliminary study of validity and acceptability. Palliat Med 1995;9:207-219. [7582177]
57. Grant M, Ferrell B, Schmidt GM, Fonbuena P, Niland JC, Forman SJ. Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res 1992;1:375-384. [1299470]
58. Ware JE Jr, Sherbourne CD.The MOS 36-item short-form health survey (SF-36):1.conceptual framework and item selection. Med Care 1992;30:473-483. [1593914]
59. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002-1012. [9674618]
60. Till JE, Osoba D, Pater JL, Young JR. Research on health-related quality of life: dissemination into practical applications. Qual Life Res 1994;3:279-283. [7812281]
61. Greenhalgh J, Long AF, Flynn R, The use of patient reported outcome measures in routine clinical practice:lack of impact or lack of theory? Soc Sci Med 2005;60:833-843. [15571900]
62. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T. Assessing clinical significance in measuring oncology patient quality of life:introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002;77:367-370. [11936934]
63. Wilson KA, Dowling AJ, Abdolell M, Tannock IF. Perception of quality of life by patients, partners and treating physicians. Qual Life Res 2000;9:1041-1052. [11332225]
64. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580-1583. [9169401]
65. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer 1999;81:87-94. [10487617]
66. Madden J.The problem of distress in patients with cancer: more effective assessment. Clin J Oncol Nurs 2006;10:615-619. [17063615]
67. Ford S, Fallowfield L, Lewis S. Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? Br J Cancer 1994;70:767-770. [7917937]
68. Merckaert I, Libert Y, Delvaux N, et al. Factors that influence physicians' detection of distress in patients with cancer:can a communication skills training program improve physicians' detection? Cancer 2005;104:411-421. [15952179]
69. Morris J, Perez D, McNoe B.The use of quality of life data in clinical practice. Qual Life Res 1998;7:85-91. [9481154]
70. Cella DF. Quality of life outcomes: measurement and validation. Oncology (Williston Park) 1996;10(11 suppl):233-246. [8953606]
71. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997;50:441-450. [9179103]
72. Velikova G, Wright EP, Smith AB, et al. Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol 1999;17:998-1007. [10071295]
73. Wright EP, Selby PJ, Crawford M, et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 2003;21:374-382. [12525532]
74. Buxton J, White M, Osoba D. Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 1998;7:513-519. [9737141]
75. Allenby A, Matthews J, Beresford J, McLachlan SA. The application of computer touch-screen technology in screening for psychosocial distress in an ambulatory oncology setting. Eur J Cancer Care (Engl) 2002;11:245-253. [12492461]
76. Drummond HE, Ghosh S, Ferguson A, Brackenridge D, Tiplady B. Electronic quality of life questionnaires:a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res 1995;4:21-26. [7711686]
77. Whitlatch CJ, Zarit SH, von Eye A.Efficacy of interventions with caregivers:a reanalysis. Gerontologist 1991;31:9-14. [2007480]
78. Novak M, Guest C. Application of a multidimensional caregiver burden inventory. Gerontologist 1989;29:798-803. [2516000]
79. McCorkle R.The measurement of symptom distress. Semin Oncol Nurs 1987;3:248-256. [3423446]
80. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs 1978;1:373-378. [250445]